Sanofi and Aqemia have reached a $140 million research collaboration agreement to use AI to accelerate the discovery of innovative drugs. The collaboration aims to identify small molecule drug candidates in the field of therapeutics. AQEMIA will utilize its unique platform combined with AI to identify therapeutic targets of interest to Sanofi. The collaboration will encompass the entire drug discovery process.